Creative Biolabs provides a high-fidelity alternative to traditional pyrogen testing, offering a robust analytical framework to detect and quantify lipopolysaccharides (LPS) with digital precision. By leveraging state-of-the-art transducers, we overcome "masking" in complex matrices, allowing for endotoxin quantification in "untestable" environments where optical methods fail. Our service ensures international pharmacopeia compliance for recombinant proteins, vaccines, and cell therapies without the variability of animal-derived reagents. This definitive digital readout guarantees batch-to-batch consistency, ensuring trace contaminants never derail your research timelines.
In modern biopharmaceuticals, even picogram levels of LPS pose lethal inflammatory risks. While the traditional LAL assay suffers from biological variability, Creative Biolabs utilizes modern biosensor technology to provide a digitalized, animal-free alternative. By integrating synthetic DNA aptamers and graphene oxide nanomaterials, our platform enables breakthroughs in single-molecule tracking and ratiometric sensing. These advancements bypass enzyme-based limitations, offering superior stability and a wide linear range for precise molecular characterization. This robust framework ensures international safety compliance for biologics while eliminating the need for animal-derived reagents.
Creative Biolabs provides a multi-modal portfolio of biosensing platforms, each engineered to address specific analytical challenges in the biopharmaceutical pipeline. Our offerings go beyond simple detection, providing deep insights into molecular interactions and contamination profiles.
We offer a dual-signal sensing platform that utilizes internal reference probes to eliminate signal drift caused by fluctuations in pH, temperature, or ionic strength. This is the gold standard for high-fidelity testing in clinical serum or concentrated protein buffers.
For projects requiring extreme sensitivity, we provide plasmonic aptasensors capable of counting individual LPS molecules. Utilizing gold nanoparticle-nanofilm coupling, this "digital" detection mode eliminates the averaging errors of ensemble measurements.
A highly selective optical offering that provides a visual or polarized light readout based on the conformational orientation of liquid crystals upon endotoxin binding.
We utilize electromagnetic piezoelectric acoustic sensing (EMPAS) to measure the absolute mass of bound endotoxins on an ultrathin surface platform, providing label-free, real-time kinetic data.
We can tailor the recognition layer of our biosensors using specific endotoxin-neutralizing proteins (ENPs) or custom-selected DNA aptamers to target specific bacterial strains or LPS subtypes relevant to your unique production process.
Inquire About Our Technology Platforms - Request a Quote
To ensure seamless integration into your quality control pipeline, Creative Biolabs follows a structured and transparent technical workflow. Our process is designed to maximize data accuracy while minimizing turnaround time, moving from initial matrix assessment to high-resolution digital quantification.
This paper reports an optical aptasensor for real-time, quantitative endotoxin detection at both ensemble and single-molecule levels. The sensor uses a gold nanoparticle tethered to a gold film via an endotoxin-specific aptamer. Target binding alters the aptamer conformation, reducing the nanoparticle-to-film distance and causing a measurable plasmonic spectral shift. This platform offers high specificity, reusability, and the unique capability for single-molecule resolution imaging, presenting a promising sustainable alternative to traditional endotoxin assays for medical and industrial applications.
Fig.1 Schematic of the sensing process.1
Creative Biolabs delivers an industry-leading non-biological endotoxin detection suite powered by nanobiotechnology. Utilizing peptide-assembled graphene oxide and AuNP signal amplification, we achieve an ultra-sensitive limit of detection (LOD) of 0.001 EU/mL. Our ratiometric electrochemical platforms reduce environmental interference by 85%, ensuring stable, reproducible results. Unlike traditional assays, our sensors exhibit superior matrix resilience, detecting LPS in 100% human serum without the "masking effect." This robust, animal-free framework provides the digital precision and batch-to-batch consistency required for the most demanding biopharmaceutical applications and clinical diagnostics.
Experience the Creative Biolabs Advantage - Get a Quote Today
Our sensors use synthetic aptamers not affected by LAL inhibitors like beta-glucans, allowing us to test "difficult" samples with high precision.
Yes, our ratiometric technology effectively filters out background noise caused by high protein concentrations.
Yes, we can functionalize sensors with custom aptamers for specific strain detection if required.
Creative Biolabs provides comprehensive endotoxin removal using membrane adsorption, ultrafiltration, and chromatography. Our proprietary non-detergent assay ensures high recovery while reducing endotoxins to undetectable levels for downstream applications.
Learn More →Creative Biolabs utilizes Triton X-114 phase extraction to remove endotoxins. By leveraging temperature transitions, endotoxins partition into the detergent phase while target proteins or pDNA remain purified in the aqueous phase.
Learn More →The demand for safer, faster, and more reliable endotoxin testing has never been higher. By integrating cutting-edge single-molecule optical sensing with ratiometric and nanocomposite-enhanced electrochemical platforms, Creative Biolabs empowers researchers and manufacturers to safeguard their biological products with absolute confidence.
Contact our scientific team to discuss how our biosensor technology can be tailored to your specific requirements.
Reference